Skip to main content
Caplight Logo









Epineuron Technologies

Epineuron Technologies

Private
Mississauga, OntarioHealthcare & Life Scienceshttps://www.epineurontech.com/

Last Round

Seed

May 28, 2020

Total Funding Raised

$1.5M

Company Overview

Epineuron Technologies is a medical device company that develops a bioelectronic therapy to accelerate the regeneration of damaged peripheral nerves.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

bioelectronic medicineelectroceuticalsnerve regenerationneurostimulationperipheral nerve repairmedical devicemedtechelectrical stimulation therapynerve stimulatorwearable medical devicesurgical nerve stimulatorperioperative therapyintraoperative neuromonitoringreconstructive surgeryFDA breakthrough designation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epineuron Technologies Comparables

Compare Epineuron Technologies with similar companies based on industry and business-model similarity.

Epineuron Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuraptive Therapeutics
81%
BioCircuit Technologies
76%
Checkpoint Surgical
73%

Epineuron Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 28, 2020

Epineuron Technologies Investors

Notable investors and investment history

Epineuron Technologies investors
InvestorRounds
Ontario Brain InstituteSeed
Ontario Centre of InnovationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2024

    Monthly visitors increased 41% MoM.

  • Aug 10, 2023

    Grew 40% QoQ, from 10 to 14 employees.

Epineuron Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epineuron Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epineuron Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersMississauga, Ontario
Employee Range14
Year Founded2016
Last FundingMay 28, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?